HK1202288A1 - -氧代-噁唑烷- -二基抗生素衍生物 - Google Patents
-氧代-噁唑烷- -二基抗生素衍生物Info
- Publication number
- HK1202288A1 HK1202288A1 HK15102622.5A HK15102622A HK1202288A1 HK 1202288 A1 HK1202288 A1 HK 1202288A1 HK 15102622 A HK15102622 A HK 15102622A HK 1202288 A1 HK1202288 A1 HK 1202288A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- oxazolidin
- diyl
- oxo
- antibiotic derivatives
- antibiotic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Detergent Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2011054968 | 2011-11-08 | ||
PCT/IB2012/056236 WO2013068948A1 (en) | 2011-11-08 | 2012-11-07 | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1202288A1 true HK1202288A1 (zh) | 2015-09-25 |
Family
ID=47258051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15102622.5A HK1202288A1 (zh) | 2011-11-08 | 2015-03-16 | -氧代-噁唑烷- -二基抗生素衍生物 |
Country Status (20)
Country | Link |
---|---|
US (1) | US9079922B2 (zh) |
EP (1) | EP2776431B1 (zh) |
JP (1) | JP6030146B2 (zh) |
KR (1) | KR20140096337A (zh) |
AR (1) | AR088691A1 (zh) |
AU (1) | AU2012335207B2 (zh) |
BR (1) | BR112014011064A8 (zh) |
CA (1) | CA2854264A1 (zh) |
CL (1) | CL2014001154A1 (zh) |
ES (1) | ES2581056T3 (zh) |
HK (1) | HK1202288A1 (zh) |
IL (1) | IL232463A0 (zh) |
IN (1) | IN2014CN04126A (zh) |
MX (1) | MX344529B (zh) |
PL (1) | PL2776431T3 (zh) |
RU (1) | RU2616609C2 (zh) |
SG (1) | SG11201401710PA (zh) |
TW (1) | TWI594996B (zh) |
WO (1) | WO2013068948A1 (zh) |
ZA (1) | ZA201404176B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104151316B (zh) | 2008-10-07 | 2016-06-15 | 埃科特莱茵药品有限公司 | 三环噁唑烷酮抗生素化合物 |
TWI631119B (zh) | 2013-04-16 | 2018-08-01 | 愛杜西亞製藥有限公司 | 抗菌雙芳香族衍生物 |
AR096135A1 (es) | 2013-05-02 | 2015-12-09 | Actelion Pharmaceuticals Ltd | Derivados de la quinolona |
AR102256A1 (es) | 2014-10-15 | 2017-02-15 | Actelion Pharmaceuticals Ltd | Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi |
MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
MA41168A (fr) | 2014-12-17 | 2017-10-24 | Acraf | Nouveaux composés antibactériens |
CA3012569A1 (en) * | 2016-02-08 | 2017-08-17 | Redx Pharma Plc | Antibacterial compounds |
BR112018016208A2 (pt) | 2016-02-08 | 2018-12-18 | Redx Pharma Plc | compostos heterocíclicos, em particular derivados 2-oxo-4,4,5,5,6,6,7,7-octahidrobenzoxazol, e seus usos como compostos antibacterianos |
GB201602235D0 (en) * | 2016-02-08 | 2016-03-23 | Redx Pharma Plc | Antibacterial compounds |
US10633366B2 (en) | 2016-06-08 | 2020-04-28 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Antibacterial compounds |
TW201833120A (zh) | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | 芳基噁唑啶酮抗生素化合物 |
FI3634968T3 (fi) | 2017-06-08 | 2023-04-26 | Bugworks Res Inc | Bakteerilääkkeinä käyttökelpoisia heterosyklisiä yhdisteitä ja menetelmä niiden valmistamiseksi |
JP7390728B2 (ja) * | 2017-11-29 | 2023-12-04 | バグワークス・リサーチ・インコーポレイテッド | 抗菌複素環式化合物及びそれらの合成 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3149104A (en) | 1961-01-03 | 1964-09-15 | Sterling Drug Inc | 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters |
DE2362553A1 (de) | 1972-12-18 | 1974-06-20 | Dainippon Pharmaceutical Co | Neue piperazinderivate |
GB1598915A (en) | 1977-09-20 | 1981-09-23 | Bellon Labor Sa Roger | 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them |
SE444566B (sv) | 1977-09-20 | 1986-04-21 | Bellon Labor Sa Roger | 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav |
CS274601B2 (en) | 1983-07-27 | 1991-09-15 | Dainippon Pharmaceutical Co | Method of 1,8-naphthyridine derivative production |
JPS62205060A (ja) | 1986-03-04 | 1987-09-09 | Kyorin Pharmaceut Co Ltd | 8位置換キノロンカルボン酸誘導体 |
FI871419A (fi) | 1986-03-31 | 1987-10-01 | Sankyo Co | Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning. |
JP2631854B2 (ja) | 1987-12-23 | 1997-07-16 | 藤本製薬株式会社 | 新規な1,8−ナフチリジン誘導体 |
DE4301246A1 (de) | 1993-01-19 | 1994-07-21 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäurederivate |
JPWO2004002973A1 (ja) | 2002-06-28 | 2005-10-27 | 株式会社カネカ | 光学活性1−置換アミノ−2,3−エポキシプロパンの製造方法並びにその合成中間体およびそれらの製造方法 |
MXPA05011654A (es) * | 2003-04-30 | 2005-12-15 | Morphochem Ag Komb Chemie | Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones. |
CN1898238A (zh) * | 2003-12-18 | 2007-01-17 | 莫弗凯姆联合化学股份公司 | 噁唑烷酮-喹诺酮杂化物抗生素 |
BRPI0514381A (pt) * | 2004-07-30 | 2008-06-10 | Palumed Sa | compostos hìbridos de aminoquinolina-antibiótico, composições farmacêuticas, método de preparação e uso destes |
AU2005279611A1 (en) | 2004-09-01 | 2006-03-09 | Ubitrak Inc. | System for gaming chip identification and counting |
US20090156577A1 (en) | 2004-09-09 | 2009-06-18 | Benjamin Davis | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
US7709496B2 (en) | 2006-04-06 | 2010-05-04 | Glaxo Group Limited | Antibacterial agents |
TWI374138B (en) * | 2006-11-10 | 2012-10-11 | Actelion Pharmaceuticals Ltd | 5-hydroxymethyl-oxazolidin-2-one derivatives |
CL2008001002A1 (es) * | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
CL2008001003A1 (es) * | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
CN101903380B (zh) * | 2007-12-18 | 2013-04-17 | 埃科特莱茵药品有限公司 | 5-氨基环甲基-噁唑啶-2-酮衍生物 |
BRPI0908208A2 (pt) * | 2008-02-22 | 2015-08-25 | Actelion Pharmaceuticals Ltd | Composto derivado de oxazolidinona, medicamento, composição farmacêutica que o contém e uso desse composto. |
CN104151316B (zh) | 2008-10-07 | 2016-06-15 | 埃科特莱茵药品有限公司 | 三环噁唑烷酮抗生素化合物 |
US20110195949A1 (en) * | 2008-10-10 | 2011-08-11 | Actelion Pharmaceuticals Ltd. | 2-benzothiophenyl- and 2-naphthyl-oxazolidinones and their azaisostere analogues as antibacterial agents |
ES2628091T3 (es) | 2008-10-10 | 2017-08-01 | Idorsia Pharmaceuticals Ltd | Antibióticos de oxazolidinilo |
TW201121965A (en) | 2009-09-28 | 2011-07-01 | Lg Life Sciences Ltd | Use of a quinolone derivative containing 7-(4-aminomethyl-3-oxime)pyrrolidine group that is capable of inducing granulocyte colony stimulating factor for treatment of neutropenia and recovery of hematopoiesis |
CN101792443A (zh) | 2010-03-09 | 2010-08-04 | 北京欧凯纳斯科技有限公司 | 氟代喹诺酮衍生物及其制备方法和用途 |
-
2012
- 2012-11-07 TW TW101141423A patent/TWI594996B/zh not_active IP Right Cessation
- 2012-11-07 IN IN4126CHN2014 patent/IN2014CN04126A/en unknown
- 2012-11-07 RU RU2014123109A patent/RU2616609C2/ru not_active IP Right Cessation
- 2012-11-07 ES ES12791863.9T patent/ES2581056T3/es active Active
- 2012-11-07 CA CA2854264A patent/CA2854264A1/en not_active Abandoned
- 2012-11-07 BR BR112014011064A patent/BR112014011064A8/pt not_active Application Discontinuation
- 2012-11-07 JP JP2014540612A patent/JP6030146B2/ja not_active Expired - Fee Related
- 2012-11-07 PL PL12791863.9T patent/PL2776431T3/pl unknown
- 2012-11-07 SG SG11201401710PA patent/SG11201401710PA/en unknown
- 2012-11-07 AU AU2012335207A patent/AU2012335207B2/en not_active Ceased
- 2012-11-07 MX MX2014005637A patent/MX344529B/es active IP Right Grant
- 2012-11-07 US US14/356,896 patent/US9079922B2/en not_active Expired - Fee Related
- 2012-11-07 EP EP12791863.9A patent/EP2776431B1/en not_active Not-in-force
- 2012-11-07 KR KR1020147014957A patent/KR20140096337A/ko active IP Right Grant
- 2012-11-07 AR ARP120104192A patent/AR088691A1/es unknown
- 2012-11-07 WO PCT/IB2012/056236 patent/WO2013068948A1/en active Application Filing
-
2014
- 2014-04-30 CL CL2014001154A patent/CL2014001154A1/es unknown
- 2014-05-05 IL IL232463A patent/IL232463A0/en unknown
- 2014-06-06 ZA ZA2014/04176A patent/ZA201404176B/en unknown
-
2015
- 2015-03-16 HK HK15102622.5A patent/HK1202288A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
IN2014CN04126A (zh) | 2015-07-10 |
AR088691A1 (es) | 2014-06-25 |
BR112014011064A8 (pt) | 2017-12-26 |
IL232463A0 (en) | 2014-06-30 |
RU2014123109A (ru) | 2015-12-20 |
ZA201404176B (en) | 2016-05-25 |
PL2776431T3 (pl) | 2016-11-30 |
JP2014532754A (ja) | 2014-12-08 |
AU2012335207A1 (en) | 2014-07-03 |
SG11201401710PA (en) | 2014-09-26 |
CL2014001154A1 (es) | 2014-09-12 |
CA2854264A1 (en) | 2013-05-16 |
US9079922B2 (en) | 2015-07-14 |
MX344529B (es) | 2016-12-19 |
RU2616609C2 (ru) | 2017-04-18 |
EP2776431A1 (en) | 2014-09-17 |
TW201326166A (zh) | 2013-07-01 |
CN103917539A (zh) | 2014-07-09 |
KR20140096337A (ko) | 2014-08-05 |
AU2012335207B2 (en) | 2017-05-25 |
MX2014005637A (es) | 2014-06-23 |
WO2013068948A1 (en) | 2013-05-16 |
JP6030146B2 (ja) | 2016-11-24 |
EP2776431B1 (en) | 2016-05-04 |
ES2581056T3 (es) | 2016-08-31 |
US20150051188A1 (en) | 2015-02-19 |
BR112014011064A2 (pt) | 2017-06-13 |
TWI594996B (zh) | 2017-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1202288A1 (zh) | -氧代-噁唑烷- -二基抗生素衍生物 | |
SG10201601802YA (en) | Dispiropyrrolidine derivatives | |
ZA201401884B (en) | New dihydroquinoline-2-one derivatives | |
IL227664A0 (en) | New heterocyclic histories | |
EP2762476A4 (en) | 1,2,4-triazine-6-carboxamide derivative | |
IL247639B (en) | History of heteroaryl piperidine | |
IL231950B (en) | Aryl-quinoline derivatives | |
HK1191653A1 (zh) | -糖苷衍生物 | |
HK1198586A1 (zh) | -二氟甲基- -二氫- 噁嗪- -胺衍生物 | |
EP2721029A4 (en) | IMIDAZOPYRIDIN-2-ONE DERIVATIVES | |
IL233001A0 (en) | New iso-ergoline histories | |
ZA201302112B (en) | 1,4-oxazepane derivatives | |
SI2766342T1 (sl) | Derivati fenil-gvanidina | |
EP2671887A4 (en) | NEW MACROLIDE DERIVATIVE | |
ZA201308049B (en) | 3-ureidoisoquinolin-8-yl derivatives | |
ZA201209319B (en) | Cyclopropyl-indole derivatives | |
GB201119592D0 (en) | Novel heteroaromatic Derivatives I | |
GB201119961D0 (en) | Antibacterial derivatives | |
GB201119958D0 (en) | Antibacterial derivatives |